Gokce Cicek Karaman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gokce Cicek Karaman has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Cz Karaman
Radiology, Adnan Menderes University, Faculty of Medicine, Aydin, Turkey
1 shared publicationE Dikicioglu
Pathology and
1 shared publication- Ekin Şavk
Department of Dermatology Aydın Adnan Menderes University Aydın Turkey
1 shared publication - Hasan Karakuş
Clinic of Medical Microbiology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey
1 shared publication - Ilgaz Kazaz
Medical Microbiology Laboratory, Beytepe Murat Erdi Eker State Hospital, 06800 Ankara, Turkey
1 shared publication - Neslihan Sendur
Department of Dermatology and Venereology, Adnan Menderes University School of Medicine, Aydın, Turkey
1 shared publication
Latest Publications
- Open Access
- 5 July 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-7
Evaluation of colistin susceptibility by four phenotypic methods compared to broth microdilution in multidrug-resistant Klebsiella pneumoniae
Colistin, one of the last-line treatment options for carbapenem-resistant microorganisms, presents challenges in determining its antimicrobial susceptibility. This study aims to compare colistin broth disk elution (CBDE), modified CBDE (mCBDE), the colistin agar test (CAT), and rapid polymyxin NP (RPNP) tests with the reference broth microdilution (BMD) in determining colistin susceptibility of 116 multidrug-resistant (MDR) Klebsiella pneumoniae isolates. Isolates were collected from blood and respiratory tract samples of different patients between 2022 and 2023 in Türkiye. For each isolate, a single 0.5 McFarland inoculum was prepared to inoculate CBDE, mCBDE, and CAT in parallel, then the suspension was adjusted to a density of 3-3.5 for RPNP. All tests were conducted simultaneously under the same incubation conditions. In the comparative analysis of the tests, bias, essential agreement (EA), and sensitivity were assessed according to ISO 20776-2:2021. Additionally, EA, categorical agreement (CA), major error (ME), and very major error (VME) were evaluated by the CLSI guidelines. The minimum inhibitory concentration (MIC) values for MIC50 and MIC90 were 2 µg/ml and 16 µg/ml, respectively. All methods achieved the CA above 90%, with no VMEs (0%). The ME rates for CBDE, mCBDE, CAT, and RPNP were 3.4%, 8.6%, 12%, and 10.3%, respectively. The EA rates of CBDE and CAT were 95.6% and 91.3%, respectively, while bias rates were 10.8% and 24.7%. The sensitivity of both mCBDE and RPNP was 100%. Consistent with other studies in this field, a comprehensive evaluation of all methods revealed that 58.3% (7/12) of the isolates responsible for MEs had an MIC value of 1 µg/ml, 25% (3/12) had an MIC of 2 µg/ml, and 16.6% (2/12) had an MIC of 0.25 µg/ml. Most errors occurred in isolates with MIC values near the breakpoint. The CBDE demonstrated the best performance in all criteria assessed. This study highlights the benefits of alternative phenotypic methods compared to reference BMD for assessing colistin susceptibility, including ease of use, cost-effectiveness, and rapid results. Our findings emphasize the need for more comprehensive multicenter studies to validate and improve these methods, especially those with more isolates with MIC values near the breakpoint.
- 5 July 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-7
Open AccessEvaluation of colistin susceptibility by four phenotypic methods compared to broth microdilution in multidrug-resistant Klebsiella pneumoniae
Colistin, one of the last-line treatment options for carbapenem-resistant microorganisms, presents challenges in determining its antimicrobial susceptibility. This study aims to compare colistin broth disk elution (CBDE), modified CBDE (mCBDE), the colistin agar test (CAT), and rapid polymyxin NP (RPNP) tests with the reference broth microdilution (BMD) in determining colistin susceptibility of 116 multidrug-resistant (MDR) Klebsiella pneumoniae isolates. Isolates were collected from blood and respiratory tract samples of different patients between 2022 and 2023 in Türkiye. For each isolate, a single 0.5 McFarland inoculum was prepared to inoculate CBDE, mCBDE, and CAT in parallel, then the suspension was adjusted to a density of 3-3.5 for RPNP. All tests were conducted simultaneously under the same incubation conditions. In the comparative analysis of the tests, bias, essential agreement (EA), and sensitivity were assessed according to ISO 20776-2:2021. Additionally, EA, categorical agreement (CA), major error (ME), and very major error (VME) were evaluated by the CLSI guidelines. The minimum inhibitory concentration (MIC) values for MIC50 and MIC90 were 2 µg/ml and 16 µg/ml, respectively. All methods achieved the CA above 90%, with no VMEs (0%). The ME rates for CBDE, mCBDE, CAT, and RPNP were 3.4%, 8.6%, 12%, and 10.3%, respectively. The EA rates of CBDE and CAT were 95.6% and 91.3%, respectively, while bias rates were 10.8% and 24.7%. The sensitivity of both mCBDE and RPNP was 100%. Consistent with other studies in this field, a comprehensive evaluation of all methods revealed that 58.3% (7/12) of the isolates responsible for MEs had an MIC value of 1 µg/ml, 25% (3/12) had an MIC of 2 µg/ml, and 16.6% (2/12) had an MIC of 0.25 µg/ml. Most errors occurred in isolates with MIC values near the breakpoint. The CBDE demonstrated the best performance in all criteria assessed. This study highlights the benefits of alternative phenotypic methods compared to reference BMD for assessing colistin susceptibility, including ease of use, cost-effectiveness, and rapid results. Our findings emphasize the need for more comprehensive multicenter studies to validate and improve these methods, especially those with more isolates with MIC values near the breakpoint.
- 15 April 2004
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 18 (3) , 334-336
Cutaneous basosquamous carcinoma infiltrating cerebral tissue
Basosquamous carcinoma of the skin is a rare malignancy with specific histopathological features of both basal cell carcinoma and squamous cell carcinoma. Some authors believe that basosquamous carcinoma is a variant of basal cell carcinoma, while others suggest that this tumour may behave more aggressively. We present a 44‐year‐old female patient who was diagnosed with a basosquamous carcinoma histopathologically. She had extensive ulcero‐vegetative lesions, involving the anterior half of the scalp, the left orbit and the left side of the face. With this case we aim to emphasize the aggressive nature of basosquamous carcinoma and review the literature.
- 15 April 2004
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 18 (3) , 334-336
Cutaneous basosquamous carcinoma infiltrating cerebral tissue
Basosquamous carcinoma of the skin is a rare malignancy with specific histopathological features of both basal cell carcinoma and squamous cell carcinoma. Some authors believe that basosquamous carcinoma is a variant of basal cell carcinoma, while others suggest that this tumour may behave more aggressively. We present a 44‐year‐old female patient who was diagnosed with a basosquamous carcinoma histopathologically. She had extensive ulcero‐vegetative lesions, involving the anterior half of the scalp, the left orbit and the left side of the face. With this case we aim to emphasize the aggressive nature of basosquamous carcinoma and review the literature.